[1] Bonora E, Kiechl S, Willeit J, et al. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes, 2004; 53, 1782-9. doi:  10.2337/diabetes.53.7.1782
[2] Sjöholm A, Nyström T. Endothelial inflammation in insulin resistance. Lancet, 2005; 365, 610-2. doi:  10.1016/S0140-6736(05)17912-4
[3] Matsumoto K, Fujita N, Ozaki M, et al. Coexistence of insulin resistance and inflammation effectively predicts cardiac disease but not stroke in Japanese patients with type 2 diabetes mellitus. Diabetes Res Clin Pract, 2006; 74, 316-21. doi:  10.1016/j.diabres.2006.04.014
[4] Natali A, Toschi E, Baldeweg S, et al. Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes. Diabetes, 2006; 55, 1133-40. doi:  10.2337/diabetes.55.04.06.db05-1076
[5] Dehghan A, van Hoek M, Sijbrands EJ, et al. Risk of type 2 diabetes attributable to C-reactive protein and other risk factors. Diabetes Care, 2007; 30, 2695-9. http://cn.bing.com/academic/profile?id=ebdc0d99b44d2474cc2fa3d9cb3a3d53&encoded=0&v=paper_preview&mkt=zh-cn
[6] Meigs JB, Hu FB, Rifai N, et al. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA, 2004; 291, 1978-86. doi:  10.1001/jama.291.16.1978
[7] Chu KY, Leung PS. Angiotensin Ⅱ in type 2 diabetes mellitus. Curr Protein Pept Sci, 2009; 10, 75-84. doi:  10.2174/138920309787315176
[8] Matsumoto K, Sera Y, Abe Y, et al. Inflammation and insulin resistance are independently related to all-cause of death and cardiovascular events in Japanese patients with type 2 diabetes mellitus. Atherosclerosis, 2003; 169, 317-21. doi:  10.1016/S0021-9150(03)00198-9
[9] Ingelsson E, Hulthe J, Lind L. Inflammatory markers in relation to insulin resistance and the metabolic syndrome. Eur J Clin Invest, 2008; 38, 502-9. doi:  10.1111/j.1365-2362.2008.01962.x
[10] Scheen AJ, Esser N, Paquot N. Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control. Diabetes Metab, 2015; 41, 183-94. doi:  10.1016/j.diabet.2015.02.003